Amaç: Prostat kanseri ve obezite ilişkisi üzerine yapılan birçok çalışmada, obezite ve artan adipozitenin radikal prostatektomi sonrası daha kötü patolojik, onkolojik ve fonksiyonel sonuçlar ile ilişkili olduğu bulunmuştur. Sürekli artan prostat kanseri insidansı ve obezite oranları düşünüldüğünde, hekimler, prostat kanserine sahip obez hastaların zorlu cerrahi yönetimi ile artan sıklıkla karşı karşıya kalmaktadır. Biz de bu çalışmamızda, prostat kanseri sebebiyle robot yardımlı radikal prostatektomi [robot-assissted radical prostatectomy (RARP)] yapılan obez ve nonobez hastaların verilerini karşılaştırmayı ve obezitenin cerrahi sonuçlar üzerindeki etkisini incelemeyi hedefledik. Gereç ve Yöntemler: Ocak 2016-Ocak 2018 yılları arasında, lokalize prostat kanseri sebebiyle uygulanan RARP operasyonuna ait veriler incelendi. Hastalara ait demografik, preoperatif, peroperatif ve postoperatif veriler kaydedildi. Postoperatif 3, 6 ve 12. ayda IIEF skorları, ayrıca postoperatif sonda çekilmesi sonrasında ve 3, 6, 9 ve 12. ayda kontinans durumları sorgulandı. Hastalar beden kitle indeksi (BKİ) skorlarına göre nonobez (Grup 1: <30 kg/m2), obez (Grup 2: >30 kg/m2) olarak 2 gruba ayrıldı ve sonuçlar karşılaştırıldı. Bulgular: RARP yapılan nonobez 73 ve obez 40 hasta çalışmaya dâhil edildi. Ortalama yaş Grup 1 ve Grup 2 için sırasıyla 60,7±5,9 ve 60,3±5,5 olarak tespit edildi ve 2 grup arasında anlamlı fark izlenmedi. BMI Grup 1 ve Grup 2 için sırasıyla 26,1±2,3 ve 31,8±3,4 olarak tespit edildi ve anlamlı fark tespit edildi. Preoperatif IIEF skorları, prostat spesifik antijen seviyeleri, prostat hacimleri arasında 2 grup arasında anlamlı fark tespit edilmedi. Ortalama operasyon ve konsol süreleri nonobez grupta anlamlı daha kısa tespit edildi. Peroperatif kanama miktarları Grup 1 ve Grup 2 için sırasıyla 85,6±23,8 ve 134,6±100,5 olarak tespit edildi ve aralarında anlamlı fark tespit edildi. Obez grubunda hastanede kalış süreleri anlamlı daha uzun olarak tespit edildi. Peroperatif ve postoperatif komplikasyon oranları ve ekstraprostatik yayılım, cerrahi sınır pozitifliği, seminal vezikül invazyonu, biyokimyasal rekürrens oranları gibi onkolojik sonuçlarda anlamlı farklılık izlenmedi. Üç, 6 ve 12. aylarda saptanan potens oranlarında ve sonda çekilmesi sonrasında, 3, 6, 9 ve 12. ayların tümünde 2 grup arasında anlamlı fark saptanmadı. Sonuç: RARP, obez hastalarda nonobez hasta grubuna benzer etkinlik ve güvenlikte uygulanabilir. Bununla birlikte, obez hasta grubunda hasta konforu ve fonksiyonel sonuçların daha kötü olduğu tespit edilmiştir.
Anahtar Kelimeler: Obezite; prostat kanseri; robotik yardımlı radikal prostatektomi
Objective: Many studies on the relationship between prostate cancer and obesity have found that obesity and increased adiposity are associated with worse pathological, oncologic and functional outcomes after radical prostatectomy. Given the ever increasing incidence of prostate cancer and obesity rates, physicians are increasingly faced with the difficult surgical management of obese patients with prostate cancer. In this study, we aimed to compare the data of obese and non-obese patients who underwent robot-assisted radical prostatectomy (RARP) for prostate cancer and to investigate the effect of obesity on surgical outcomes. Material and Methods: Data of RARP operation performed for localized prostate cancer between January 2016-January 2018 were reviewed. Demographic, preoperative, peroperative and postoperative data of the patients were recorded. IIEF scores were evaluated at 3, 6 and 12 months postoperatively, as well as continence status after postoperative catheter withdrawal and at 3, 6, 9 and 12 months. Patients were divided into two groups according to body mass index (BMI) scores as non-obese (Group 1: <30 kg/m2) and obese (Group 2: >30 kg/m2) and the results were compared. Results: 73 non-obese and 40 obese patients who underwent RARP were included in the study. The mean age for Group 1 and Group 2 was 60.7±5.9 and 60.3±5.5, respectively, and there was no significant difference between the two groups. BMI for Group 1 and Group 2 were 26.1±2.3 and 31.8±3.4, respectively, and a significant difference was found. Preoperative IIEF scores, prostate specific antigen levels, prostate volumes were not significantly different between the two groups. Mean operation and console times were significantly shorter in non-obese group. Peroperative hemorrhage amounts for Group 1 and Group 2 were 85.6±23.8 and 134.6±100.5, respectively. The length of hospital stay was significantly longer in the obese group. Peroperative and postoperative complication rates and oncologic results such as extraprostatic extension, surgical margin positivity, seminal vesicle invasion, biochemical recurrence rates were not significantly different. No significant difference was found between the 2 groups in the 3, 6, 9, and 12 months after the potency ratios detected at 3,6 and 12 months. Conclusion: RARP can be applied in obese patients with similar efficacy and safety as non-obese patients. However, patient comfort and functional outcomes were found to be worse in the obese group.
Keywords: Obesity; prostate cancer; robotic assisted radical prostatectomy
- Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635-43. [Crossref] [PubMed]
- Perlow JH, Morgan MA. Massive maternal obesity and perioperative cesarean morbidity. Am J Obstet Gynecol. 1994;170(2):560-5. [Crossref]
- Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2011;4(4):486-501. [Crossref] [PubMed] [PMC]
- Keto CJ, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, et al. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database. BJU Int. 2012;110(4):492-8. [Crossref] [PubMed] [PMC]
- Parker AS, Thiel DD, Bergstralh E, Carlson RE, Rangel LJ, Joseph RW, et al. Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies. Prostate Cancer Prostatic Dis. 2013;16(4):352-6. [Crossref] [PubMed] [PMC]
- Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;63(5):800-9. [Crossref] [PubMed] [PMC]
- Siddiqui SA. Obesity and prostate cancer: an insight into postmodern medicine. J Urol. 2009;182(1):14-5. [Crossref] [PubMed]
- Wolfram M, Bräutigam R, Engl T, Bentas W, Heitkamp S, Ostwald M, et al. Robotic-assisted laparoscopic radical prostatectomy: the Frankfurt technique. World J Urol. 2003;21(3):128-32. [Crossref] [PubMed]
- Gu X, Araki M, Wong C. Does elevated body mass index (BMI) affect the clinical outcomes of robot-assisted laparoscopic prostatectomy (RALP): a prospective cohort study. Int J Surg. 2014;12(10):1055-60. [Crossref] [PubMed]
- Kamerer A, Basler J, Thompson I. Novel technique of Vest suture vesicourethral anastomosis in morbidly obese patient undergoing radical retropubic prostatectomy. J Urol. 2003;170(1):174. [Crossref] [PubMed]
- Froehner M, Litz R, Manseck A, Hakenberg OW, Leike S, Albrecht DM, et al. Relationship of comorbidity, age and perioperative complications in patients undergoing radical prostatectomy. Urol Int. 2001;67(4):283-8. [Crossref] [PubMed]
- Boczko J, Melman A. Radical perineal prostatectomy in obese patients. Urology. 2003;62(3):467-9. [Crossref]
- Brown JA, Rodin DM, Lee B, Dahl DM. Laparoscopic radical prostatectomy and body mass index: an assessment of 151 sequential cases. J Urol. 2005;173(2):442-5. [Crossref] [PubMed]
- Ahlering TE, Eichel L, Edwards RA, Lee DI, Skarecky DW. Robotic radical prostatectomy: a technique to reduce pT2 positive margins. Urology. 2004;64(6):1224-8. [Crossref] [PubMed]
- Tewari A, Kaul S, Menon M. Robotic radical prostatectomy: a minimally invasive therapy for prostate cancer. Curr Urol Rep. 2005;6(1):45-8. [Crossref] [PubMed]
- Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009;55(5):1037-63. [Crossref] [PubMed]
- Kopp RP, Han M, Partin AW, Humphreys E, Freedland SJ, Parsons JK. Obesity and prostate enlargement in men with localized prostate cancer. BJU Int. 2011;108(11):1750-5. [Crossref] [PubMed]
- Xu T, Wang X, Xia L, Zhang X, Qin L, Zhong S, et al. Robot-assisted prostatectomy in obese patients: how influential is obesity on operative outcomes? J Endourol. 2015;29(2):198-208. [Crossref] [PubMed]
- Khaira HS, Bruyere F, O'Malley PJ, Peters JS. Costello AJ. Does obesity influence the operative course or complications of robot-assisted laparoscopic prostatectomy. BJU Int. 2006;98(6):1275-8. [Crossref] [PubMed]
- Mikhail AA, Stockton BR, Orvieto MA, Chien GW, Gong EM, Zorn KC, et al. Robotic-assisted laparoscopic prostatectomy in overweight and obese patients. Urology. 2006;67(4):774-9. [Crossref] [PubMed]
- Castle EP, Atug F, Woods M, Thomas R, Davis R. Impact of body mass index on outcomes after robot assisted radical prostatectomy. World J Urol. 2008;26(1):91-5. [Crossref] [PubMed]
- Boorjian SA, Crispen PL, Carlson RE, Rangel LJ, Karnes RJ, Frank I, et al. Impact of obesity on clinicopathologic outcomes after robot-assisted laparoscopic prostatectomy. J Endourol. 2008;22(7):1471-6. [Crossref] [PubMed]
- Targher G, Zoppini G, Moghetti P, Day CP. Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver. Semin Thromb Hemost. 2010;36(1):41-8. [Crossref] [PubMed]
- Bae JJ, Choi SH, Kwon TG, Kim TH. Advantages of robot-assisted laparoscopic radical prostatectomy in obese patients: comparison with the open procedure. Korean J Urol. 2012;53(8):536-40. [Crossref] [PubMed] [PMC]
- Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol. 1984;120(2):244-50. [Crossref] [PubMed]
- Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev. 2001;10(4):345-53.
- Bhayani SB, Pavlovich CP, Strup SE, Dahl DM, Landman J, Fabrizio MD, et al. Laparoscopic radical prostatectomy: a multi-institutional study of conversion to open surgery. Urology. 2004;63(1):99-102. [Crossref] [PubMed]
.: Process List